2023-03-01 2024-02-29 false Capium Accounts Production 1.1 12468476 2023-03-01 2024-02-29 12468476 bus:FullAccounts 2023-03-01 2024-02-29 12468476 bus:FRS102 2023-03-01 2024-02-29 12468476 bus:AuditExemptWithAccountantsReport 2023-03-01 2024-02-29 12468476 bus:SmallCompaniesRegimeForAccounts 2023-03-01 2024-02-29 12468476 bus:PrivateLimitedCompanyLtd 2023-03-01 2024-02-29 12468476 2023-03-01 2024-02-29 12468476 2024-02-29 12468476 bus:RegisteredOffice 2023-03-01 2024-02-29 12468476 core:WithinOneYear 2024-02-29 12468476 core:AfterOneYear 2024-02-29 12468476 1 2023-03-01 2024-02-29 12468476 bus:Director1 2023-03-01 2024-02-29 12468476 bus:Director1 2024-02-29 12468476 bus:Director1 2022-03-01 2023-02-28 12468476 2022-03-01 12468476 bus:LeadAgentIfApplicable 2023-03-01 2024-02-29 12468476 2022-03-01 2023-02-28 12468476 2023-02-28 12468476 core:WithinOneYear 2023-02-28 12468476 core:AfterOneYear 2023-02-28 12468476 bus:EntityAccountantsOrAuditors 2022-03-01 2023-02-28 12468476 bus:OrdinaryShareClass1 2023-03-01 2024-02-29 12468476 bus:OrdinaryShareClass1 2024-02-29 12468476 bus:OrdinaryShareClass1 2022-03-01 2023-02-28 12468476 bus:OrdinaryShareClass1 2023-02-28 12468476 core:CostValuation core:Non-currentFinancialInstruments 2024-02-29 12468476 core:CostValuation core:Non-currentFinancialInstruments 2023-02-28 12468476 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2024-02-29 12468476 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2024-02-29 12468476 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2024-02-29 12468476 core:Non-currentFinancialInstruments 2024-02-29 12468476 core:Non-currentFinancialInstruments 2023-02-28 12468476 core:ShareCapital 2024-02-29 12468476 core:ShareCapital 2023-02-28 12468476 core:RetainedEarningsAccumulatedLosses 2024-02-29 12468476 core:RetainedEarningsAccumulatedLosses 2023-02-28 12468476 core:ShareCapitalOrdinaryShares 2023-03-01 12468476 core:ShareCapitalOrdinaryShares 2022-03-01 12468476 core:ShareCapitalOrdinaryShares 2023-03-01 2024-02-29 12468476 core:ShareCapitalOrdinaryShares 2022-03-01 2023-02-28 12468476 core:ShareCapitalOrdinaryShares 2024-02-29 12468476 core:ShareCapitalOrdinaryShares 2023-02-28 12468476 core:RetainedEarningsAccumulatedLosses 2023-03-01 12468476 core:RetainedEarningsAccumulatedLosses 2022-03-01 12468476 core:RetainedEarningsAccumulatedLosses 2023-03-01 2024-02-29 12468476 core:RetainedEarningsAccumulatedLosses 2022-03-01 2023-02-28 12468476 core:RetainedEarningsAccumulatedLosses 2024-02-29 12468476 core:RetainedEarningsAccumulatedLosses 2023-02-28 12468476 dpl:Item1 2023-03-01 12468476 dpl:Item1 2024-02-29 12468476 dpl:Item1 2022-03-01 12468476 dpl:Item1 2023-02-28 iso4217:GBP xbrli:shares xbrli:pure

Registered Number: 12468476
Unaudited Financial Statements
for the year ended 29 February 2024
for
LONDON LASER CLINIC MAIDA VALE LTD

LONDON LASER CLINIC MAIDA VALE LTD Contents Page For the year ended 29 February 2024
Company information | 1
Director's report | 2
Accountants' report | 3
Statement of financial position | 4
Notes to the financial statements | 5
Statement of changes in equity | 6

LONDON LASER CLINIC MAIDA VALE LTD Company Information For the year ended 29 February 2024
Director | SURTI Sara Dhada
Registered Number | 12468476
Registered Office | 4 SUTHERLAND AVENUE LONDON ENGLAND W9 2HQ
Accountants | Hartrose Associates Ltd 17 The Triangle Huddersfield HD 4RN
1

LONDON LASER CLINIC MAIDA VALE LTD Director's Report For the year ended 29 February 2024
Director's report and financial statements The director presents his/her/their annual report and the financial statements for the year ended 29 February 2024. Principal activities Principal activity of the company during the financial year was of beauty treatment. Director The director who served the company throughout the year was as follows:
SURTI Sara Dhada
Statement of director's responsibilities The director is responsible for preparing the directors' report and the financial statements in accordance with applicable law and regulations and in accordance with United Kingdom Generally Accepted Accounting Practice. Company law requires the director to prepare financial statements for each financial year. Under that law the director has elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the director must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and the profit or loss of the company for that period. In preparing these financial statements, the director is required to : select suitable accounting policies and then apply them consistently make judgements and accounting estimates that are reasonable and prudent state whether applicable UK Accounting Standards have been followed, subject to any material departures disclosed and explained in the financial statements and prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business. The director is responsible for keeping adequate accounting records that are sufficient to show and explain the company’s transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. The director is also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities. The director is responsible for the maintenance and integrity of the corporate and financial information included on the company's website. Legislation in the United Kingdom, governing the preparation and dissemination of financial statements, may differ from legislation in other jurisdictions On behalf of the board.
---------------------------------- SURTI Sara Dhada Director
Date approved: 24 May 2025 2

LONDON LASER CLINIC MAIDA VALE LTD Accountants' Report For the year ended 29 February 2024
You consider that the company is exempt from an audit for the year ended 29 February 2024 . You have acknowledged, on the balance sheet, your responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts. These responsibilities include preparing accounts that give a true and fair view of the state of affairs of the company at the end of the financial year and of its profit or loss for the financial year. In accordance with your instructions, we have prepared the accounts which comprise the Profit and Loss Account, the Statement of Comprehensive Income, the Balance Sheet, the Statement of Changes in Equity and the related notes from the accounting records of the company and on the basis of information and explanations you have given to us. We have not carried out an audit or any other review, and consequently we do not express any opinion on these accounts. .................................................... Hartrose Associates Ltd 17 The Triangle Huddersfield HD 4RN 24 May 2025 3

LONDON LASER CLINIC MAIDA VALE LTD Statement of Financial Position As at 29 February 2024
| Notes | 2024 £ |  | 2023 £
--- | --- | --- | --- | ---
Current assets |  |  |
Debtors | 3 | 79,690 |  | 79,690
Cash at bank and in hand |  | 7,082 |  | 7,082
|  | 86,772 |  | 86,772
Creditors: amount falling due within one year | 4 | (17,006) |  | (17,006)
Net current assets |  | 69,766 |  | 69,766
Total assets less current liabilities |  | 69,766 |  | 69,766
Creditors: amount falling due after more than one year | 5 | (35,840) |  | (35,840)
Net assets |  | 33,926 |  | 33,926
Capital and reserves |  |  |
Called up share capital | 6 | 1 |  | 1
Profit and loss account |  | 33,925 |  | 33,925
Shareholders' funds |  | 33,926 |  | 33,926
For the year ended 29 February 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. Director's responsibilities: The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476. The director acknowledges their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts. These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. In accordance with Section 444 of the Companies Act 2006, the income statement has not been delivered to the Registrar of Companies. The financial statements were approved by the director on 24 May 2025 and were signed by:
------------------------------- SURTI Sara Dhada Director
4

LONDON LASER CLINIC MAIDA VALE LTD Statement of Changes in Equity For the year ended 29 February 2024
|  | Equity share capital |  | Retained Earnings |  | Total
| £ |  | £ |  | £ |
At 01 March 2022 |  | 1 |  | 3,348 |  | 3,349
Profit for the year |  |  |  | 30,577 |  | 30,577
Total comprehensive income for the year |  | - |  | 30,577 |  | 30,577
Total investments by and distributions to owners |  | - |  | - |  | -
At 28 February 2023 |  | 1 |  | 33,925 |  | 33,926
At 01 March 2023 |  | 1 |  | 33,925 |  | 33,926
Total comprehensive income for the year |  | - |  | - |  | -
Total investments by and distributions to owners |  | - |  | - |  | -
At 29 February 2024 |  | 1 |  | 33,925 |  | 33,926
5

LONDON LASER CLINIC MAIDA VALE LTD Notes to the Financial Statements For the year ended 29 February 2024
General Information LONDON LASER CLINIC MAIDA VALE LTD is a private company, limited by shares, registered in , registration number 12468476, registration address 4 SUTHERLAND AVENUE, LONDON ENGLAND, W9 2HQ. The presentation currency is £ sterling.
1. | Accounting policies Significant accounting policies Statement of compliance These financial statements have been prepared in compliance with FRS 102 – The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006. Basis of preparation The financial statements have been prepared under the historical cost convention as modified by the revaluation of land and buildings and certain financial instruments measured at fair value in accordance with the accounting policies. The financial statements are prepared in sterling which is the functional currency of the company. Turnover Turnover comprises the invoiced value of goods and services supplied by the company, net of Value Added Tax and trade discounts.
2. | Average number of employees Average number of employees during the year was 1 (2023 : 0).
3. | Debtors: amounts falling due within one year
| 2024 £ |  | 2023 £
--- | --- | --- | ---
Other Debtors | 79,690 |  | 79,690
| 79,690 |  | 79,690
4. | Creditors: amount falling due within one year
| 2024 £ |  | 2023 £
--- | --- | --- | ---
Corporation Tax | 7,957 |  | 7,957
Accrued Expenses | 1,750 |  | 1,750
Directors' Current Accounts | 7,299 |  | 7,299
| 17,006 |  | 17,006
5. | Creditors: amount falling due after more than one year
| 2024 £ |  | 2023 £
--- | --- | --- | ---
Bank Loans & Overdrafts | 35,840 |  | 35,840
| 35,840 |  | 35,840
6. | Share Capital
Allotted, called up and fully paid | 2024 £ |  | 2023 £
--- | --- | --- | ---
1 Class A share of £1.00 each | 1 |  | 1
| 1 |  | 1
6